chr17-48543457-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002145.4(HOXB2):āc.682C>Gā(p.Pro228Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,606,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002145.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HOXB2 | NM_002145.4 | c.682C>G | p.Pro228Ala | missense_variant | 2/2 | ENST00000330070.6 | |
HOXB2 | XM_005257275.5 | c.355C>G | p.Pro119Ala | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HOXB2 | ENST00000330070.6 | c.682C>G | p.Pro228Ala | missense_variant | 2/2 | 1 | NM_002145.4 | P1 | |
HOXB2 | ENST00000571287.1 | n.327C>G | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152034Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000428 AC: 1AN: 233502Hom.: 0 AF XY: 0.00000775 AC XY: 1AN XY: 129014
GnomAD4 exome AF: 0.00000619 AC: 9AN: 1454762Hom.: 0 Cov.: 33 AF XY: 0.00000968 AC XY: 7AN XY: 723450
GnomAD4 genome AF: 0.000125 AC: 19AN: 152034Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.682C>G (p.P228A) alteration is located in exon 2 (coding exon 2) of the HOXB2 gene. This alteration results from a C to G substitution at nucleotide position 682, causing the proline (P) at amino acid position 228 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at